In The News
Herbert Smith Freehills leaders vote to remove partner over ‘offensive’ tweet
Senior counsel for Super Retail execs withdraws, citing ethical concerns
Sacked execs’ claim about settlement ‘fanciful’, says Rebel Sport owner
Monash IVF class action wants bulk of late members shut out of $56M deal
Spotless, Ventia in court over alleged price-fixing on Defence contracts
King & Wood Mallesons snags employment group from Corrs
Ousted Liberal MP awarded $300,000 in defamation case against party leader
Kraken crypto exchange operator Bit Trade must pay $8M penalty
Funder behind WestConnex class action hit with indemnity costs
Viva Energy’s proposed acquisition of LOC Global gets ACCC’s OK
Please login to bookmarkClose

Medical device maker Bayer has successfully defended a class action over its Essure contraceptive, with a judge finding the evidence fell short of proving the device caused chronic inflammation.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au